ArticleScientific reports2026
Challenges in strengthening sentinel surveillance network during COVID-19 pandemic in Africa.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The emergence of variants in the wake of the COVID-19 pandemic has put a strain on healthcare systems in Africa. The Afroscreen project is strengthening national sentinel surveillance systems, combined with sequencing capabilities to identify potentially highly virulent variants of interest at an early stage. The aim of this article is to present the results of this project and discuss the related challenges. Surveillance was based on national surveillance sentinel systems, either hospital-based or peripheral, and RT-PCR diagnostic capabilities, coupled with sequencing in the event of positivity, from July 2022 to June 2024. In 11 African countries (Senegal, Guinea, Côte d'Ivoire, Togo, Benin, Niger, Cameroon, the Central African Republic (CAR), Burkina Faso, Madagascar and the Democratic Republic of the Congo), it was possible to demonstrate a decline in the circulation of SARS-CoV-2 over the surveillance period, with only the Omicron variant circulating. Setting up and coordinating a multicountry sentinel surveillance system during a pandemic period is a real challenge. This highlights the need to strengthen surveillance systems during interepidemic and pandemic periods and the question of their sustainability in line with emerging disease preparedness and response programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.